Nuveen Asset Management, LLC Viracta Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $329 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.87 - $5.0 $268,294 - $717,365
-143,473 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.23 - $4.76 $3,443 - $7,349
1,544 Added 1.09%
143,473 $475,000
Q4 2021

Feb 14, 2022
SELL
$3.37 - $7.91 $32,112 - $75,374
-9,529 Reduced 6.29%
141,929 $479,000
Q3 2021

Nov 12, 2021
BUY
$7.84 - $12.53 $29,196 - $46,661
3,724 Added 2.52%
151,458 $1.32 Million
Q2 2021

Aug 16, 2021
BUY
$7.55 - $12.95 $1.12 Million - $1.91 Million
147,734 New
147,734 $1.68 Million

Others Institutions Holding VIRX

# of Institutions
43
Shares Held
9.39M
Call Options Held
5.9K
Put Options Held
0
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $18.4M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email